187 related articles for article (PubMed ID: 30207064)
1. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.
Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
Pediatr Blood Cancer; 2019 Jan; 66(1):e27454. PubMed ID: 30207064
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.
Shioda Y; Adachi S; Imashuku S; Kudo K; Imamura T; Morimoto A
Int J Hematol; 2011 Dec; 94(6):545-51. PubMed ID: 22139588
[TBL] [Abstract][Full Text] [Related]
3. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
4. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis.
Nakagawa S; Shinkoda Y; Hazeki D; Imamura M; Okamoto Y; Kawakami K; Kawano Y
J Pediatr Endocrinol Metab; 2016 Jul; 29(7):873-8. PubMed ID: 27089406
[TBL] [Abstract][Full Text] [Related]
5. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis.
Lian H; Cui L; Yang Y; Wei A; Cheng H; Li N; Zhang L; Ma H; Zhao X; Wang T; Li Z; Zhang R
Pituitary; 2022 Feb; 25(1):108-115. PubMed ID: 34302575
[TBL] [Abstract][Full Text] [Related]
6. Relapses of multisystem/multifocal bone Langerhans cell histiocytosis in paediatric patients: Data analysis from the JLSG-96/02 study.
Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
Br J Haematol; 2023 Mar; 200(6):769-775. PubMed ID: 36511451
[TBL] [Abstract][Full Text] [Related]
7. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
9. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
[TBL] [Abstract][Full Text] [Related]
10. [Thickening of the pituitary stalk in children and adolescents with central diabetes insipidus: Causes and consequences].
Corredor Andrés B; Muñoz Calvo MT; López Pino MÁ; Márquez Rivera M; Travieso Suárez L; Pozo Román J; Argente J
An Pediatr (Engl Ed); 2019 May; 90(5):293-300. PubMed ID: 29895434
[TBL] [Abstract][Full Text] [Related]
11. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.
Prosch H; Grois N; Prayer D; Waldhauser F; Steiner M; Minkov M; Gadner H
Pediatr Blood Cancer; 2004 Oct; 43(5):594-9. PubMed ID: 15382278
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
Huang JB; Xue HM; Chen YY; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China.
Ji X; Wang Z; Wang W; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Front Endocrinol (Lausanne); 2020; 11():76. PubMed ID: 32153511
[No Abstract] [Full Text] [Related]
14. Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall.
Prosch H; Grois N; Bökkerink J; Prayer D; Leuschner I; Minkov M; Gadner H
Pediatr Blood Cancer; 2006 Mar; 46(3):363-6. PubMed ID: 15942956
[TBL] [Abstract][Full Text] [Related]
15. [Outcome Comparison of Pediatric Langerhans Cell Histiocytosis Treated with Modified DAL-HX83/90 or JLSG-96 Protocol].
Huang JB; Jiang L; Chen C; Xue HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1190-5. PubMed ID: 27531798
[TBL] [Abstract][Full Text] [Related]
16. Late outcomes in children with Langerhans cell histiocytosis.
Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
[TBL] [Abstract][Full Text] [Related]
17. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.
Vaiani E; Felizzia G; Lubieniecki F; Braier J; Belgorosky A
Horm Res Paediatr; 2021; 94(1-2):9-17. PubMed ID: 34167121
[TBL] [Abstract][Full Text] [Related]
18. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies.
Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
Br J Haematol; 2021 Feb; 192(3):615-620. PubMed ID: 33236384
[TBL] [Abstract][Full Text] [Related]
19. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
[TBL] [Abstract][Full Text] [Related]
20. Endocrine features of Langerhans cell histiocytosis in paediatric patients: A 30-year review.
Alexander A; Zacharin M
J Paediatr Child Health; 2024 Jan; 60(1):24-27. PubMed ID: 38031464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]